Back to search

Poland· PL-100008760

Bals Sulphur żel

A medicinal product containing preparat złożony, registered in Poland by Przedsiębiorstwo Farmaceutyczne SULPHUR ZDRÓJ Exim Sp. z o.o..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBals Sulphur żelATC—REGISTER NO.PL-100008760PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Preparat złożony
Manufacturer
Przedsiębiorstwo Farmaceutyczne SULPHUR ZDRÓJ Exim Sp. z o.o.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990354511

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8cdaf172-ccd1-4f04-9950-e3d5f47348c4
GET /v1/drugs/8cdaf172-ccd1-4f04-9950-e3d5f47348c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Żel",
  "source": "urpl",
  "strength": "-",
  "packaging": "OTC ¦ Skasowane ¦ 1717\n1 op. 200 g\nOTC ¦ Skasowane ¦ 1718\n1 op. 250 g\n05909990354511 ¦ OTC ¦ 1719\n1 op. 300 g",
  "substance": "Woda chlorkowo-sodowa (solanka), siarczkowa, fluorkowa, jodkowa 96,50 g/100 g",
  "common_name": "Preparat złożony",
  "pl_product_id": "100008760",
  "pozwolenie_nr": "03545",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about preparat złożony.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.